Heterogeneity in 5-HT-induced contractile and proliferative responses in rat pulmonary arterial bed

Journal of Vascular Research

Volumn 45, Issue 3, 2008, Pages 181-192

  Rodat Despoix, L ^a   Crevel, H ^a   Marthan, R ^a   Savineau, J P ^a   Guibert, C ^a  

^a INSERM   (France)

Author keywords

Excitation contraction coupling; Pulmonary circulation; Serotonin; Serotonin receptors; Smooth muscle cell proliferation; Vascular smooth muscle

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 5 CARBAMOYLTRYPTAMINE; ALPHA METHYLSEROTONIN; KETANSERIN; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; NITRENDIPINE; RHO KINASE; RITANSERIN; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; THAPSIGARGIN;

ANIMAL CELL; ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; SMOOTH MUSCLE FIBER;

AMIDES; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; ENZYME INHIBITORS; MALE; MITOGENS; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RHO-ASSOCIATED KINASES; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 42149175480     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111071     Document Type: Article

References (38)

1. Smirnov SV, Beck R, Tammaro P, Ishii T, Aaronson PI: Electrophysiologically distinct smooth muscle cell subtypes in rat conduit and resistance pulmonary arteries. J Physiol 2002;538:867-878.
2. Park KS, Lee HA, Earm KH, Ko JH, Earm YE, Kim SJ: Differential distribution of mechanosensitive nonselective cation channels in systemic and pulmonary arterial myocytes of rabbits. J Vasc Res 2006;43:347-354.
3. Franco-Obregon A, Lopez-Barneo J: Differential oxygen sensitivity of calcium channels in rabbit smooth muscle cells of conduit and resistance pulmonary arteries. J Physiol 1996;491:511-518.
4. - currents in pulmonary arterial myocytes. Am J Physiol 1996;270:H1577-H1584.
5. MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M, Morecroft I: 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br J Pharmacol 1996;119:917-930.
6. Leach RM, Twort CH, Cameron IR, Ward JP: A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat. Clin Sci (Lond) 1992;82:55-62.
7. Hyvelin JM, Guibert C, Marthan R, Savineau JP: Cellular mechanisms and role of endothelin-1-induced calcium oscillations in pulmonary arterial myocytes. Am J Physiol 1998;275:L269-L282.
8. Chootip K, Ness KF, Wang Y, Gurney AM, Kennedy C: Regional variation in P2 receptor expression in the rat pulmonary arterial circulation. Br J Pharmacol 2002;137:637-646.
9. MacLean MR, Herve P, Eddahibi S, Adnot S: 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol 2000;131:161-168.
10. Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, Adnot S: Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: relationship with the mitogenic action of serotonin. Circ Res 1999;84:329-336.
11. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP: International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203.
12. 1-adrenoceptor in the contractile response of rat pulmonary artery to 5-HT in the presence and absence of nitric oxide. Pulm Pharmacol Ther 2000;13:277-285.
13. 1B/1D-receptor antagonist GR127935. Circ Res 2001;89:1231-1239.
14. Thomas BJ, Wanstall JC: Alterations in pulmonary vascular function in rats exposed to intermittent hypoxia. Eur J Pharmacol 2003;477:153-161.
15. 1B/1D-mediated contraction in pulmonary arteries. Br J Pharmacol 2003;138:795-800.
16. Hong Z, Olschewski A, Reeve HL, Nelson DP, Hong F, Weir EK: Nordexfenfluramine causes more severe pulmonary vasoconstriction than dexfenfluramine. Am J Physiol Lung Cell Mol Physiol 2004;286:L531-L538.
17. Guibert C, Marthan R, Savineau JP: 5-HT induces an arachidonic acid-sensitive calcium influx in rat small intrapulmonary artery. Am J Physiol Lung Cell Mol Physiol 2004;286:L1228-L1236.
18. Yuan XJ, Bright RT, Aldinger AM, Rubin LJ: Nitric oxide inhibits serotonin-induced calcium release in pulmonary artery smooth muscle cells. Am J Physiol 1997;272:L44-L50.
19. Rodat L, Savineau JP, Marthan R, Guibert C: Effect of chronic hypoxia on voltage-independent calcium influx activated by 5-HT in rat intrapulmonary arteries. Pflügers Arch 2007;454:41-51.
20. Low AM, Kotecha N, Neild TO, Kwan CY, Daniel EE: Relative contributions of extracellular Ca2+ and Ca2+ stores to smooth muscle contraction in arteries and arterioles of rat, guinea-pig, dog and rabbit. Clin Exp Pharmacol Physiol 1996;23:310-316.
21. Stiebellehner L, Frid MG, Reeves JT, Low RB, Gnanasekharan M, Stenmark KR: Bovine distal pulmonary arterial media is composed of a uniform population of well-differentiated smooth muscle cells with low proliferative capabilities. Am J Physiol Lung Cell Mol Physiol 2003;285:L819-L828.
22. Pitt BR, Weng W, Steve AR, Blakely RD, Reynolds I, Davies P: Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am J Physiol 1994;266:L178-L186.
23. Guibert C, Savineau JP, Crevel H, Marthan R, Rousseau E: Effect of short-term organoid culture on the pharmaco-mechanical properties of rat extra- and intrapulmonary arteries. Br J Pharmacol 2005;146:692-701.
24. Trian T, Girodet PO, Ousova O, Marthan R, Tunon-de-Lara JM, Berger P: RNA interference decreases PAR-2 expression and function in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2006;34:49-55.
25. 2 receptor subtypes: a family re-united? Trends Pharmacol Sci 1995;16:105-110.
26. 1B/D receptor antagonists. Gen Pharmacol 1997;29:293-303.
27. 2+ pump blockers: thapsigargin and cyclopiazonic acid. Pflügers Arch 1995;429:617-624.
28. Janssen LJ, Lu-Chao H, Netherton S: Excitation-contraction coupling in pulmonary vascular smooth muscle involves tyrosine kinase and Rho kinase. Am J Physiol Lung Cell Mol Physiol 2001;280:L666-L674.
29. Khan I, Oriowo MA, Chandrasekhar B, Kadavil EA: Attenuated noradrenaline-induced contraction of pulmonary arteries from rats treated with monocrotaline: role of rho kinase. J Vasc Res 2005;42:433-440.
30. Nagaoka T, Morio Y, Casanova N, Bauer N, Gebb S, McMurtry I, Oka M: Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 2004;287:L665-L672.
31. Chand N, Altura BM: Reactivity and contractility of rat main pulmonary artery to vasoactive agents. J Appl Physiol 1980;49:1016-1021.
32. Wang HL, Dong X, Zhang XH, Xing J: 5-HT1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats. Acta Pharmacol Sin 2001;22:269-273.
33. Jeffery TK, Wanstall JC: Comparison of pulmonary vascular function and structure in early and established hypoxic pulmonary hypertension in rats. Can J Physiol Pharmacol 2001;79:227-237.
34. Uma S, Tuncer M, Kayaalp SO: The subtype of serotonin (5-HT) receptors in the rat pulmonary artery. Arch Int Pharmacodyn Ther 1987;288:248-255.
35. Morecroft I, Loughlin L, Nilsen M, Colston J, Dempsie Y, Sheward J, Harmar A, MacLean MR: Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries. J Pharmacol Exp Ther 2005;313:539-548.
36. Skingle M, Beattie DT, Scopes DI, Starkey SJ, Connor HE, Feniuk W, Tyers MB: GR127935: a potent and selective 5-HT1D receptor antagonist. Behav Brain Res 1996;73:157-161.
37. Robertson TP, Dipp M, Ward JP, Aaronson PI, Evans AM: Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat. Br J Pharmacol 2000;131:5-9.
38. Jeffery TK, Wanstall JC: Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 2001;92:1-20.